Increased Adherence after Switch From Twice Daily Calcineurin Inhibitor Based Treatment to Once Daily Modified Released Tacrolimus in Heart Transplantation: A Pre-experimental Study

被引:38
|
作者
Doesch, A. O. [1 ]
Mueller, S. [1 ]
Konstandin, M. [1 ]
Celik, S. [1 ]
Erbel, C. [1 ]
Kristen, A. [1 ,2 ]
Frankenstein, L. [1 ]
Koch, A.
Dengler, T. J. [1 ]
Ehlermann, P. [1 ]
Zugck, C. [1 ]
De Geest, S. [3 ]
Katus, H. A. [1 ]
机构
[1] Heidelberg Univ, Dept Cardiol, D-6900 Heidelberg, Germany
[2] Heidelberg Univ, Dept Cardiovasc Surg, Heidelberg, Germany
[3] Univ Basel, CH-4003 Basel, Switzerland
关键词
PROGRAF-BASED REGIMEN; 2 YEARS POSTCONVERSION; RECIPIENTS; FORMULATION; MEDICATION; CONVERSION; THERAPY; NONADHERENCE; EXPERIENCE; OUTCOMES;
D O I
10.1016/j.transproceed.2010.09.074
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Modified release tacrolimus (TAC) is a new, once-daily oral formulation of the established immunosuppressive agent TAC. Simplification of regimen has been associated with better adherence. This study evaluated patient adherence, as well as safety and efficacy among chronic stable heart transplantation (HT) patients switched from a conventional twice daily calcineurin inhibitor-based regimen (TAC or cyclosporine A [CsA]) to (once daily) modified release TAC. Methods. We switched 54 chronic stable patients (41 males and 13 females) from twice daily dosing with conventional TAC or CsA to once daily dosing with modified release TAC. Self-reported adherence was assessed at baseline and at 4 months after the switch using the Basel Assessment of Adherence with Immunosuppressive Medication Scale [BAASIS]), a 4-item validated questionnaire including also a Visual Analogue Scale (VAS). Nonadherence was defined as any self-reported nonadherence on any item. Results. Modified release TAC was discontinued in 4 patients because of diarrhea (n = 1) or gastrointestinal discomfort (n = 3) leaving 50 evaluable patients. Overall nonadherence at baseline for any of the 4 items was 74% versus 38% after 4 months (P = .0001). Thereafter, adherence improved in 28 patients (56.0%), was unchanged in 18 (36.0%), and decreased in 4 subjects (8.0%). The VAS score improved from 82.3% +/- 2.6% to 97.5% +/- 4.8% (P < .0001). No significant changes were observed after 4 months regarding hematologic, renal, or liver function parameters (all P = NS). Conclusions. Therapeutic regimens for transplant recipients are often complex, contributing to a high incidence of medication nonadherence. This study in chronic, stable, heart transplantation patients demonstrated a significant improvement in patient adherence after a switch to modified release TAC, which was generally well tolerated.
引用
收藏
页码:4238 / 4242
页数:5
相关论文
共 50 条
  • [1] Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation
    Doesch, Andreas O.
    Mueller, Susanne
    Akyol, Ceylan
    Erbel, Christian
    Frankenstein, Lutz
    Ruhparwar, Arjang
    Ehlermann, Philipp
    Dengler, Thomas J.
    Katus, Hugo A.
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 : 1253 - 1258
  • [2] Switch From Twice-Daily Tacrolimus (Prograf) To Once-Daily Prolonged-Release Tacrolimus (Advagraf) in Lung Transplantation
    Jaksch, P.
    Stromberger, R.
    Murakoezy, G.
    Lambers, C.
    Klepetko, W.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S67 - S68
  • [3] Switch from Twice-Daily Tacrolimus (Prograf) to Once-Daily Prolonged-Release Tacrolimus (Advagraf) in Kidney Transplantation
    Iaria, G.
    Sforza, D.
    Angelico, R.
    Toti, L.
    de Luca, L.
    Manuelli, M.
    Bellini, I.
    Manzia, T. M.
    Anselmo, A.
    Tisone, G.
    [J]. TRANSPLANTATION PROCEEDINGS, 2011, 43 (04) : 1028 - 1029
  • [4] Pharmacokinetic Study of Conversion from Tacrolimus Twice-Daily to Tacrolimus Once-Daily in Stable Lung Transplantation
    Mendez, Alejandra
    Berastegui, Cristina
    Lopez-Meseguer, Manuel
    Monforte, Victor
    Bravo, Carlos
    Blanco, Albert
    Camos, Silvia
    Pou, Leonor
    Roman, Antonio
    [J]. TRANSPLANTATION, 2014, 97 (03) : 358 - 362
  • [5] Conversion from Tacrolimus or Ciclosporine twice-daily to Tacrolimus once-daily in adolescents after pediatric liver transplantation
    Weil, T.
    Debray, D.
    Kramer, L.
    Habes, D.
    Taburet, A. -M.
    Furlan, V.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (01) : 144 - 144
  • [6] SWITCH FROM TWICE-DAILY TACROLIMUS TO ONCE-DAILY PROLONGED RELEASE TACROLIMUS IN KIDNEY TRANSPLANTATION: LONG-TERM OUTCOME
    Sforza, Daniele
    Iaria, Giuseppe
    Petagna, Lorenzo
    Pellicciaro, Marco
    Vella, Ivan
    Sergi, Filomena Diletta
    Marzio, Silvio
    Telli, Sara
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 480 - 481
  • [7] Conversion from twice daily tacrolimus to once daily modified release tacrolimus in stable pancreas transplant recipients - a safety study
    Laurence, Jerome
    Dib, Martin J.
    Barbas, Andrew S.
    Marquez, Max A.
    Sapisochin, Gonzalo
    Norgate, Andrea
    Schiff, Jeffrey
    McGilvray, Ian D.
    Selzner, Markus
    Greig, Paul D.
    Cattral, Mark S.
    [J]. XENOTRANSPLANTATION, 2015, 22 : S33 - S33
  • [8] Conversion from tacrolimus twice-daily (Prograf) to tacrolimus once-daily (Advagraf) in adolescents after pediatric liver transplantation
    Weil, T.
    Debray, D.
    Kramer, L.
    Habes, D.
    Taburet, A. M.
    Furlan, V
    [J]. THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 536 - 537
  • [9] Tacrolimus Exposure Before and After a Switch From Twice-Daily Immediate-Release to Once-Daily Prolonged Release Tacrolimus: The ENVARSWITCH Study
    Monchaud, Caroline
    Woillard, Jean-Baptiste
    Crepin, Sabrina
    Tafzi, Naima
    Micallef, Ludovic
    Rerolle, Jean-Philippe
    Dharancy, Sebastien
    Conti, Filomena
    Choukroun, Gabriel
    Thierry, Antoine
    Buchler, Matthias
    Salame, Ephrem
    Garrouste, Cyril
    Duvoux, Christophe
    Colosio, Charlotte
    Merville, Pierre
    Anglicheau, Dany
    Etienne, Isabelle
    Saliba, Faouzi
    Mariat, Christophe
    Debette-Gratien, Marilyne
    Marquet, Pierre
    [J]. TRANSPLANT INTERNATIONAL, 2023, 36
  • [10] Switch From Twice-daily Tacrolimus to Once-daily, Prolonged-release Tacrolimus in Kidney Transplantation: Long-term Outcome
    Sforza, D.
    Laria, G.
    Petagna, L.
    Parente, A.
    Anselmo, A.
    Sergi, F.
    Marzio, S.
    Corrado, F.
    Telli, S.
    Manzia, T. M.
    Tisone, G.
    [J]. TRANSPLANTATION PROCEEDINGS, 2019, 51 (01) : 140 - 142